Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.18%
#2 0G 0G +27.29%
#3 Pons Pons +26.97%
#4 SAFEcoin SAFEcoin +26.87%
#5 Zora Zora +25.96%
#6 Seeker Seeker +23.15%
#7 VVS Finance VVS Finance +21.62%
#8 Full Moon Full Moon +17.50%
#9 ADO Protocol ADO Protocol +16.58%
#10 Apertum Apertum +15.82%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Rangering i aksjer #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Aksjekurs
$4.99
Markedsverdi
$508.03M
Endring (1 dag)
-2.48%
Endring (1 år)
2.10%
Land
TW
Handel Ever Supreme Bio Technology Co., Ltd (6712)

Kategori

Healthcare
Inntekter for Ever Supreme Bio Technology Co., Ltd (6712)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Ever Supreme Bio Technology Co., Ltd er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Ever Supreme Bio Technology Co., Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH